Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Clin Gastroenterol. 2013 Jul;47 Suppl:S30-6. doi: 10.1097/MCG.0b013e31829440bd.

Surgical therapy for hepatocellular carcinoma: formulating a rational approach.

Author information

  • 1Department of Surgical Oncology and GI Surgery, Yale University School of Medicine, New Haven, CT 06510, USA. charles.cha@yale.edu

Abstract

Hepatocellular carcinoma is one of the most common malignancies worldwide, and its incidence continues to rise in the United States. Partial hepatectomy and liver transplantation remains the mainstay of treatment for localized disease and provides significant improvement in long-term survival, as well as the potential for cure. The indications and criteria for resection and transplantation are well established, but continue to undergo significant modification over time. Surgical resection is the primary therapeutic modality in patients with well-compensated liver disease, and transplantation is highly effective in early-stage tumors in patients with severe underlying liver disease. The relative role for each of these modalities must be tailored to individual patients based on a rational approach designed to balance quality of life, organ allocation, and patient survival.

PMID:
23751801
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk